Imexhs Ltd · ASX:IME
Imexhs — Investor Presentation (February 2022)
31 slides from Imexhs's investor presentation, Feb 28, 2022
Slide 1: FY21 Results
FY21 Results Presenters 28 February 2022 Dr German Arango, CEO Reena Minhas, CFO
Slide 2: Agenda
Agenda FY21 Results 1. IMEXHS Overview 2. FY21 Results Overview 3. FY21 Financials 4. Strategy & Outlook 2
Slide 3: Overview
imexHSs Overview
Slide 4: One Company with two businesses
One Company with two businesses aimed at democratising access to medical expertise Medical Imaging Software Radiology Services Provider of innovative, cloud-based, Outsourcing of imaging facilities AI medical imaging software and teleradiology to hospitals and solutions medical facilities 4
Slide 5: Expanding global footprint
Expanding global footprint Software Services 15 countries; 386 Colombia, Spain and sites Mexico 2,400+ radiologists 33 radiology centres 35 distributors in 17 100+ in-house radiologists countries 37 engineers 5
Slide 6: FY21 Results Overview
ime «Hs FY21 Results Overview
Slide 7: FY21 Operational Highlights
FY21 Operational Highlights • AQUILA in the Cloud – 111 active contracts with ARR of $2.5m; 75% of contracts outside Colombia • Entered into a global commercial partnership with Neusoft Medical • Launched IMEXHS Cloud to provide better access to IMEXHS’s cloud portfolio of products • Purchased radio
Slide 8: FY21 Financial Highlights
FY21 Financial Highlights Sales Revenue1 Annual Recurring EBITDA Revenue (ARR) Up 23% yoy $13.4m Up 102% yoy $20.4m vs ($1.3m) in FY20 ($3.0m) Up 34% on a constant Up 121% on a constant due to continued currency basis currency basis investment in operations Recurring Closing cash Underlying revenue
Slide 9: FY21 Revenue and ARR Split
FY21 Revenue and ARR Split Medical • Software revenue primarily Radiology related to sales of AQUILA $M Software Total Services Enterprise Imaging • Radiology services includes Revenue 5.0 8.3 13.4 RIMAB along with other services related to outsourcing radiology ARR 7.1 13.3 20.4 on-premise or remot
Slide 10: Software – AQUILA Enterprise
Software – AQUILA Enterprise Number of Studies (m) 7.5m +21.3% • Enterprise imaging platform tailored to a customer’s specific needs (formerly 6.2m AQUILA Custom) • Dedicated to large university hospitals and multi-site healthcare organisations • Average contract length is 5 years • ~100 customers a
Slide 11: Software – AQUILA in the Cloud (AiC)
Software – AQUILA in the Cloud (AiC) Annualised Recurring Revenue ($'000) and # of contracts • Standardised radiology solution launched in 2500 May 2020; unique and successful offering in an 2100 underpenetrated global market 2000 • Provides small and medium-sized customers with low-cost, rapidly de
Slide 12: Radiology Services
Radiology Services • Outsourced radiology services for hospitals and other establishments • includes administration, technicians, enterprise software, training, equipment if required; radiologists located on premise and internal 33 Radiology Centres teleradiology • 95%+ of revenues • Teleradiology s
Slide 13: Artificial Intelligence
Artificial Intelligence • Key differentiator and competitive advantage Number of Images Stored (m) • Connection between 2 businesses – radiology services and technology 1504 • AI tools – Chest, COVID, Lung, Neuro*, Breast*, Braviz 940 • Elements for successfully building AI tools: 1. Data 2. Experie
Slide 14: FY21 Financials
imex<«Hs FY21 Financials
Slide 15: Strong growth in ARR
Strong growth in ARR 25 +102% yoy (+121% on a constant currency basis) 20 15 A$ Millions Constant currency basis assumes that historic 10 results are converted at the 31 Dec-21 exchange rate. This removes the impact of changes in currency rates and allows comparison of 5 IMEXHS’s underlying operatin
Slide 16: Income Statement
Income Statement $'000 FY21 FY20 Var Var % • Revenue of $13.4m, up 23% with 90% recurring revenue Revenue 13,373 10,914 2,459 23% • Total expenses of $18.1m, up 25% on Other revenue 216 88 128 145% pcp, reflect increased investment in Total revenue 13,589 11,002 2,587 24% sales and marketing, expand
Slide 17: Balance Sheet
Balance Sheet $'000 Dec 21 Jun 21 Dec 20 • Balance Sheet reflects the acquired Cash 4,186 8,342 10,796 assets and liabilities of RIMAB Trade & other receivables 7,264 4,609 4,059 • Increase in Intangible assets reflects Inventories 84 197 390 recognition of $5.3m of Goodwill and Current assets 11,53
Slide 18: Summary Cash Flow
Summary Cash Flow $'000 FY21 FY20 • FY21 operating outflows of $3.0m Net cash used in operating activities (2,968) (1,467) reflecting increased investment in Net cash used in investing activities (3,386) (2,187) sales and marketing, expanding operations in Australia and the US Net cash flow from fin
Slide 19: Strategy & Outlook
imexHs Strategy & Outlook
Slide 20: Global market opportunity
Global market opportunity Large and growing addressable markets • IMEXHS’s main software market is currently in radiology in Colombia • 75% of AQUILA in the Cloud deals are from outside Colombia • US accounts for ~40% of the radiology software market; Florida market is >3x the size of the Colombian
Slide 21: Industry trends and strategic priorities
INDUSTRY TRENDS: Healthcare IT sector Use of radiological Chronic global Large, growing, techniques in Increased value radiologist Shift from client fragmented global wider clinical coming from shortage driving server architecture medical imaging applications, Artificial demand for to cloud solution
Slide 22: 2022 Product Roadmap
2022 Product Roadmap Making good progress on software developments IMEXHS AI IMEXHS Cloud Core element of the new software Cloud based medical imaging development roadmap, attempting to platform that provides a way to enhance the AI integration engine. manage medical imaging offering advanced techno
Slide 23: FY22 Outlook
FY22 Outlook AQUILA Enterprise – post COVID Global expansion – fuelled by recovery reactivating purchase recent Neusoft Medical activity; investment in sales and partnership, entry into Thailand marketing to accelerate growth and greater presence in the US AQUILA in the Cloud (AiC) – US expansion –
Slide 24: Q&A
Q&A
Slide 25: Appendix
imexHs Appendix
Slide 26: IMEXHS Enterprise Imaging Universe
IMEXHS Enterprise Imaging Universe IMEXHS Enterprise Imaging Solutions are cloud-based and manage, store, distribute, view and analyse images in three ologies – radiology, pathology and cardiology. 26
Slide 27: A Combined Offering
A Combined Offering FUTURE RADIOLOGY CHAIN Patient Scan PACS1 The role of technology in radiology, in particular AI, will Physician Full process of increase in the future. In-house Cloud image/report transfer powered by software MEDICAL IMAGING SOFTWARE Artificial • Technology such as AI, software a
Slide 28: End-to-end modular imaging solution
End-to-end modular imaging solution Scan scheduled via our platform Uploaded to IMEXHS platform Archived on IMEXHS Cloud platform Manages Billing } 1) Business Intelligence 2)Statistical Data 3. 4. 5. 1. Radiologist Referring Billing 2. Physician interprets Physician reviews (where Patient has reque
Slide 29: Glossary
Glossary Artificial intelligence (AI) tools aid Medical verticals are market Streaming technology transfers the interpretation of radiological segments that refer to specific medical images from our VNA to our images which require access to large diagnostic departments within Web Viewer, reducing th
Slide 30: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 31: FY21 Results
FY21 Results 28 February 2022